Shareholders' Equity (Details) - USD ($)		3 Months Ended		9 Months Ended	12 Months Ended
	Aug. 03, 2017	Mar. 31, 2018	Mar. 31, 2017	Sep. 30, 2016	Dec. 31, 2017
Shareholders' Equity (Textual)
Stock based compensation		$ 1,023,496	$ 633,609
Gross proceeds from equity	$ 7,000,000
Stock Award Agreements [Member]
Shareholders' Equity (Textual)
Stock based compensation		$ 944,300
2015 Equity Plan [Member]
Shareholders' Equity (Textual)
Shares of restricted common stock issued		200,000			200,000
Shares vest upon consummation of equity and/or debt financing		$ 77,983		$ 5,000,000	$ 77,983
Aggregate shares of restricted common stock				1,349,000
SAB Amendments [Member]
Shareholders' Equity (Textual)
Recognized total expense		$ 39,791
Restricted common stock, description	The SAB Amendments extend the term of the agreements from May 1, 2017 until April 30, 2018 and provide for the following equity based compensation: (a) for Dr. Frost, a warrant to purchase 2,000,000 shares of the Company's Common Stock (the "Frost Warrant") and an award of 150,000 shares of the Company's unregistered restricted Common Stock and (b) for Mr. Rubin, an award of 100,000 shares of the Company's unregistered restricted Common Stock. The restricted stock vests upon the occurrence of a change of control (as defined in the SAB Amendments).
Warrant Term	5 years
Warrant exercise price	$ 1.00